FR6315M - - Google Patents

Info

Publication number
FR6315M
FR6315M FR109211A FR109211A FR6315M FR 6315 M FR6315 M FR 6315M FR 109211 A FR109211 A FR 109211A FR 109211 A FR109211 A FR 109211A FR 6315 M FR6315 M FR 6315M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR109211A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR6315M publication Critical patent/FR6315M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR109211A 1966-06-06 1967-06-06 Expired FR6315M (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25026/66A GB1186863A (en) 1966-06-06 1966-06-06 Salts of 6-Phosphogluconic Acid and Pharmaceutical Compositions containing 6-Phosphogluconic Acid or Salts thereof

Publications (1)

Publication Number Publication Date
FR6315M true FR6315M (enExample) 1968-09-16

Family

ID=10221022

Family Applications (2)

Application Number Title Priority Date Filing Date
FR108859A Expired FR6547M (enExample) 1966-06-06 1967-06-02
FR109211A Expired FR6315M (enExample) 1966-06-06 1967-06-06

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR108859A Expired FR6547M (enExample) 1966-06-06 1967-06-02

Country Status (5)

Country Link
US (1) US3639594A (enExample)
BE (2) BE699554A (enExample)
CA (1) CA948630A (enExample)
FR (2) FR6547M (enExample)
GB (1) GB1186863A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2129833B1 (enExample) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
US5474739A (en) * 1978-02-04 1995-12-12 Interface, Inc. Microbiocidal composition
US5133933A (en) * 1983-08-16 1992-07-28 Interface Research Corporation Microbiocidal preservative
US4935232A (en) * 1983-08-16 1990-06-19 Interface Research Corporation Microbiocidal composition and method of preparation thereof
US4908209A (en) * 1983-08-16 1990-03-13 Interface, Inc. Biocidal delivery system of phosphate ester and method of preparation thereof
US5032310A (en) * 1983-08-16 1991-07-16 Interface, Inc. Microbiocidal cleansing and disinfecting formulations and preparation thereof
US5024840A (en) * 1984-03-08 1991-06-18 Interface, Inc. Antimicrobial carpet and carpet tile
US5453275A (en) * 1988-05-05 1995-09-26 Interface, Inc. Biocidal polymeric coating for heat exchanger coils
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
CL2018002863A1 (es) * 2018-10-08 2019-03-29 Rubisco Biotechnology Extracto acuosos a partir de células de fitzroya cupressoides (alerce) con propiedades antienvejecimiento y en la regeneración de la piel
CN115364110B (zh) * 2022-09-16 2024-05-07 复旦大学 6-磷酸葡萄糖酸及其衍生物在制备预防或治疗糖代谢紊乱性疾病药物中的应用

Also Published As

Publication number Publication date
GB1186863A (en) 1970-04-08
US3639594A (en) 1972-02-01
FR6547M (enExample) 1968-12-16
BE699553A (enExample) 1967-11-16
CA948630A (en) 1974-06-04
BE699554A (enExample) 1967-11-16

Similar Documents

Publication Publication Date Title
FR6547M (enExample)
AT281852B (enExample)
AU5917865A (enExample)
AU428063B2 (enExample)
AU1141566A (enExample)
AU415165B1 (enExample)
AU414526B2 (enExample)
AU417216B2 (enExample)
AU6597365A (enExample)
AU1111066A (enExample)
AU218666A (enExample)
AU6703465A (enExample)
AU1144366A (enExample)
AU5895065A (enExample)
AU1393566A (enExample)
BE675139A (enExample)
BE662818A (enExample)
BE693361A (enExample)
BE693881A (enExample)
AU855865A (enExample)
BE693934A (enExample)
AU411645B2 (enExample)
AU92366A (enExample)
BE675237A (enExample)
BE692448A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse